about
Simultaneous activation of complement and coagulation by MBL-associated serine protease 2Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiencyFourier transform infrared spectroscopic study of Ca2+ and membrane-induced secondary structural changes in bovine prothrombin and prothrombin fragment 1.Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulationProthrombin activation on the activated platelet surface optimizes expression of procoagulant activity.The measurement of thrombin in clotting blood by radioimmunoassayProthrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism.Relationship between platelet secretion and prothrombin cleavage in native whole blood.Identification of a congenital dysthrombin, thrombin Quick.Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va.The Dual Regulatory Role of Amino Acids Leu480 and Gln481 of Prothrombin.Membrane binding induces lipid-specific changes in the denaturation profile of bovine prothrombin. A scanning calorimetry study.Fate of membrane-bound reactants and products during the activation of human prothrombin by prothrombinase.Zinc metalloproteinase ProA directly activates Legionella pneumophila PlaC glycerophospholipid:cholesterol acyltransferaseA dimeric form of prothrombin on membrane surfaces.Contribution of amino acid region 334-335 from factor Va heavy chain to the catalytic efficiency of prothrombinase.The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
P2860
Q33291115-24507363-4514-4447-828C-F4401AD0FA0DQ33478715-A0456871-2A9C-42C4-91FF-79E43D869D46Q34087564-4BED0235-875A-44DA-BCC8-0192F38E4E7CQ34623120-3E7F83FE-DD99-4C5A-89BB-D350BE956253Q34667573-33FEF19E-04CA-4696-90E2-9545D45FEAEEQ35905215-A805A44F-6FB9-4816-907C-2B0EF3B85692Q36385811-7C69BF5A-8E26-4253-B61A-395F0EB60C79Q37001801-A517C426-8576-4EC0-8AB5-A58AE2EF3FABQ37024420-D37573A1-F602-4C0F-967B-6DEF7B1406B8Q37609598-3CBE845B-8186-4D3F-9C1D-E1A450DB117BQ40280737-EEED10DC-6641-4B69-95A4-F09DF05DBC6FQ41143333-3300E721-2170-4936-AE12-EC48B69C265DQ41819023-0EA04961-5597-4E94-B229-F6C8F7936EA5Q41953518-1F5D22B0-FC86-432D-8AAC-7C31A2DC963BQ42159826-FEFDF8FC-F709-4BA5-8796-83A85FAF727EQ42287626-64269AEB-6EBB-4BF1-9E68-AB1BBB88C637Q42844019-32EBB858-1246-4266-B347-12E6E53F0AC1
P2860
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh-hant
name
Human prothrombin activation.
@en
type
label
Human prothrombin activation.
@en
prefLabel
Human prothrombin activation.
@en
P2093
P1476
Human prothrombin activation.
@en
P2093
P304
P407
P577
1975-12-01T00:00:00Z